Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin-Euglycemia Therapy in Acute Aluminum Phosphide Poisoning
PACTR202008534546951Phase 2Completed
- Sponsor
- Tanta University
- Start
- Aug 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of human insulin in Aluminium phosphide poisoning (2 arms), sponsored by Tanta University. Primary endpoint: Mortality. Started Aug 2020; status: completed.
02
Drugs
human insulin
03
Conditions
Aluminium phosphide poisoning
Beyond the preview
Go deeper on PACTR202008534546951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202008534546951.